title: Effect of prostacyclin on platelet intracellular free calcium concentration of hypertensive and normotensive humans.
abstract: Platelet intracellular free calcium concentration ([Ca2+]i) has been reported to be increased in essential hypertensive patients (EHT) as compared with normotensive controls (NT). Prostacyclin (PGI2), which influences cellular Ca2+, has been reported to be reduced in EHT. This study tested the hypothesis that the resting level of platelet [Ca2+]i in humans is influenced by PGI2. We also investigated the role of PGI2 in regulating platelet [Ca2+]i of 28 EHT subjects compared to 28 NT controls. Platelet [Ca2+]i was measured using the fluorescent Ca2+ probe fura-2 under control conditions and a 10-min preincubation with PGI2. Simultaneous measurement of platelet cyclic-adenosine 3':5'-monophosphate (cAMP) was performed by radioimmunoassay. The resting level of platelet [Ca2+]i was significantly higher in EHT than in NT (32.7 +/- 1.4 v 28.3 +/- 0.9 nmol/L; P < .01). PGI2 from 30 nM to 1 mumol/L lowered the resting level of platelet [Ca2+]i in a dose-dependent manner (EHT -22.2 +/- 2.4, NT -22.9 +/- 2.3%, 1 mumol/L PGI2); however, no significant difference in platelet [Ca2+]i was observed between NT and EHT. While prostacyclin induced a transient rise in platelet cAMP, the magnitude of PGI2-induced cAMP level was similar between the two groups. These results do not support the hypothesis that endogenous PGI2 activity contributes to the increased level of platelet [Ca2+]i in EHT, although PGI2 incubation lowered the resting level of platelet [Ca2+]i.
authors.affiliation: Second Department of Medicine, Sapporo Medical College, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Komura
authors.forename: R D
authors.initials: RD
authors.lastname: Bukoski
authors.forename: N
authors.initials: N
authors.lastname: Karanja
authors.forename: C D
authors.initials: CD
authors.lastname: Morris
authors.forename: T
authors.initials: T
authors.lastname: Shingu
authors.forename: D A
authors.initials: DA
authors.lastname: McCarron
mesh_terms: D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000097:blood*; D006152:Cyclic GMP / Q000097:blood; D011464:Epoprostenol / Q000494:pharmacology*; D005260:Female; D016257:Fura-2; D006801:Humans; D006973:Hypertension / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013050:Spectrometry, Fluorescence
chemical_list: D011464:Epoprostenol; D006152:Cyclic GMP; D002118:Calcium; D016257:Fura-2